Nhau
Matambudziko mukurapa chirwere chefungal chinopararira muvarwere vane chirwere cheropa: Ruzivo kubva kuASH 2024
PaMusangano weGore negore weASH wa2024, Purofesa Sun Yuqian vakagovana tsvakiridzo yavo inoshamisa pamusoro pechirwere chefungus chinopararira (bIFD) muvarwere vane marara eropa, vachiratidza matambudziko ekuongorora nekurapa, pamwe neruzivo rwakavakirwa pazvidzidzo zvazvino.
Kufambira Mberi muT-ALL Risk Stratification: NGS-Based Classification Inoona Mapoka Madiki Ane Njodzi Yakawanda
Chidzidzo chitsva chakaburitswa mu Ropa inovandudza kupatsanurwa kwengozi dzeT-cell acute lymphoblastic leukemia (T-ALL) ichishandisa next-generation sequencing (NGS), ichivandudza kufanotaura kwekufanotaura kwechirwere uye kuona mapoka madiki ane njodzi anogona kubatsirwa nemishonga yakatarwa.
Kugadzirisa Matambudziko Enguva Refu Ekurapa kweCAR-T: Ruzivo Kubva kuCancer Yezvisikwa
Chidzidzo chakabudiswa munguva pfupi yapfuura mu Kenza yezvisikwa inoratidza matambudziko enguva refu ekurapwa kweCAR-T cell, ichinyanya kutarisa njodzi dzehutachiona uye kenza yemhando yechipiri, uye inopa nzira dzekuvandudza mhedzisiro yemurwere.
Kubudirira Muzvidzidzo | Chikwata Chekurapa chaLu Daopei Chaburitsa Chidzidzo Chekiriniki Chinoshamisa muBritish Journal of Haematology
Chikwata cheLu Daopei Medical Team, chinotungamirwa naDr. Cao Xingyu naProf. Lu Peihua, chakaburitsa bepa rekutsvaga rekiriniki rakakosha mu Chinyorwa cheBritish cheHematology (Impact Factor 5.1). Chidzidzo ichi chinoongorora kuchengetedzeka uye kushanda kwe allogeneic hematopoietic hematopoietic stem cell transplantation (allo-HSCT) mushure me autologous CD7 CAR-T therapy ye refractory uye recurred T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma (R/R T-ALL/T-LBL).
Nyaya yeMurwere | Acute Myeloid Leukemia (AML-M2) Akapona: Makore 9 Mushure mekuisirwa, Kugamuchira Simba reTariro nekuzvarwa patsva
Nyaya yemurwere inobaya mwoyo kubva kuLu Daopei Hospital, ichiratidza rwendo rwemurume ane makore makumi matatu nemaviri ekuberekwa akapona AML-M2 uyo, mushure mekuisirwa haploidentical stem cell, anopemberera makore mapfumbamwe ekuregererwa, achirarama hupenyu hwakazara uye hwakasimba, achikurudzirwa nerudo, tariro, uye kushinga.
Kuvandudzwa Kwemari Yekurarama neBu/Cy+Melphalan uye Bu/Cy+Thiotepa Regimens muHaploidentical Stem Cell Transplantation yeNon-Down Syndrome Acute Megakaryoblastic Leukemia (AMKL)
Chidzidzo chakaitwa paASH 2024 naDr. Zhi-Jie Wei nechikwata chake kuLu Daopei Hospital chinoratidza kushanda kwemaitiro eBu/Cy-based regimens akagadziriswa mu haploidentical hematopoietic stem cell transplantation yeNon-Down Syndrome Acute Megakaryoblastic Leukemia (AMKL), zvichiratidza mhedzisiro inovimbisa yekurarama kwevarwere vane relievement yakakwana (CR).
Mhedzisiro Inovimbisa yeKurapa kweCD7 CAR-T muKurapa Relapsed/Refractory Peripheral T-Cell Lymphoma paASH 2024
PaMusangano weGore negore weASH wa2024, Purofesa Lu Peihua vekuLu Daopei Hospital vakapa mhedzisiro inoshamisa kubva mukuyedzwa kwechikamu chekutanga cheCD7 CAR-T cell therapy ye relapse/refractory peripheral T-cell lymphoma (R/R PTCL), zvichiratidza kushanda zvakanaka uye kuchengetedzeka kunogoneka.
Kukunda Matambudziko muCAR-T Therapy yeT-Cell Blood Cancers
Kunyange hazvo kurapwa neCAR-T kwakachinja kurapa kwegomarara reB-cell, matambudziko makuru achiripo mukurapa gomarara reT-cell. Ongororo ichangobva kuitwa inoongorora kuoma kwekurapa neCAR-T mugomarara reropa reT-cell uye mhinduro dzinogona kutorwa kuti dzikunde zvipingamupinyi izvi.
Kufambira Mberi Mukurapa Kwemutsetse Wekutanga Kwevanhu Vakuru B-ALL: Ongororo Yakakwana kubva kuThe Lancet Haematology
Ongororo ichangobva kuitwa mu Kurapwa kweLancet Hematology inoratidza kufambira mberi kukuru mukurapa kwekutanga kweB-cell Acute Lymphoblastic Leukemia (B-ALL) yemunhu mukuru achangobva kuongororwa, ichinyanya kutarisa nzira dzekurapa dzakagadzirwa nemunhu, kurapa kutsva kwekudzivirira muviri, uye mhedzisiro yemurwere iri nani.
Mwana Ari Kuyaruka Anodzoka Netariro Mushure mekuongororwa kweAML M4a Rwendo rweKutsungirira uye Kupora
Mushure mekurwara nechirwere cheAcute myeloid leukemia (AML-M4a) uye kuisirwa stem cell inoponesa hupenyu, murwere wechidiki anowana tariro, hutano, uye kutanga patsva, nekuda kwekutarisirwa kwakanaka kweLu Daopei Hospital.
Kufambira Mberi Kutsva muKurapwa neKuongororwa kwePrimary Central Nervous System Lymphoma (PCNSL)
Kufambira mberi munguva pfupi yapfuura mukuongorora nekurapa chirwere chePrimary Central Nervous System Lymphoma (PCNSL) kwapa tariro itsva kuvarwere. Ongororo yakaitwa kubva kuStanford University inoratidza kukosha kwekuongororwa nekukurumidza uye nzira dzekurapa dzichangoburwa, kusanganisira chemotherapy uye nzira dzekurapa dzakanangana.
Nyaya yeMurwere: Kukunda Acute Myeloid Leukemia uye Kuberekwazve Mushure mekuisirwa Stem Cell
Murwere wechirume ane makore makumi matatu nemana ekuberekwa anotaura nezverwendo rwake runokurudzira rwekurwisa chirwere cheAcute myeloid leukemia (AML), achirapwa kakawanda nechemotherapy uye achiisirwa stem cell, uye achipemberera makore matatu ekupora uye tariro itsva.